Report Id: HIVYIM0222
Vaginal Yeast Infection Market Size by Drug Type (Fluconazole, Nystatin, Flucytosine and Others), By Route of Administration (Oral and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), By Region (North America, Europe, Asia-Pacific, Rest of the World), Market Analysis Report, Forecast 2023-2028
The Vaginal Yeast Infection Market is expected to be around US$ 1,500 Million by 2028 at a CAGR of 5% in the given forecast period.
COVID-19 Impact Analysis Report
"Get Latest Updated Reports as per the COVID-19 Impact"
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HEREMARKET SNAPSHOT
Major Players
- Astellas Pharma Inc
- Astra Zeneca
- Abbott Laboratories
- Allergan
- Brundavan Laboratories Private Limited
Study period:
Fastest Growing Market:
2023-2028
APAC
Base Year:
Largest Market:
2022
North America
CAGR:
5
REPORT DESCRIPTION
The Vaginal Yeast Infection Market is expected to be around US$ 1,500 Million by 2028 at a CAGR of 5% in the given forecast period.
The incidence of the autoimmune disease is a vital driver for the vaginal yeast infection market. Autoimmune diseases can result in numerous problems in the patients. The common level of yeast in the body can lead to an infection in an autoimmune condition. To regulate the yeast infection the requirement for drugs, ointment, cream and treatment is important. Because of eating habits and lifestyle changes individuals are suffering from an autoimmune disorder. The growth of this disease results in increased adoption of vaginal yeast infection treatment which propels market growth. In addition to this, a rise in vaginal yeast infection among female population is another factor propelling the demand. Moreover, the developing new types of treatments are another factor catalyzing vaginal yeast infection market demand.
The global Vaginal Yeast Infection market is segregated on the basis of Drug Type as Fluconazole, Nystatin, Flucytosine and Others. Based on Route of Administration the global Vaginal Yeast Infection market is segmented in Oral and Topical. Based on Distribution Channel the global Vaginal Yeast Infection market is segmented in Hospital Pharmacies, Retail Pharmacies and Online Pharmacies.
The global Vaginal Yeast Infection market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Vaginal Yeast Infection market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Astellas Pharma Inc, Astra Zeneca, Abbott Laboratories, Allergan, Brundavan Laboratories Private Limited, Bayer, Corden Pharma, Merck & Co., Inc., Novartis, Pfizer Inc, Synmedic Laboratories, Sanofi, and others are among the major players in the global Vaginal Yeast Infection market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Vaginal Yeast Infection Market has been segmented as below:
Vaginal Yeast Infection Market, By Drug Type
- Fluconazole
- Nystatin
- Flucytosine
- Others
Vaginal Yeast Infection Market, By Route of Administration
- Oral
- Topical
Vaginal Yeast Infection Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Vaginal Yeast Infection Market, By Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Vaginal Yeast Infection Market, By Company
- Astellas Pharma Inc
- Astra Zeneca
- Abbott Laboratories
- Allergan
- Brundavan Laboratories Private Limited
- Bayer
- Corden Pharma
- Merck & Co., Inc.
- Novartis
- Pfizer Inc
- Synmedic Laboratories
- Sanofi
The report covers:
- Global Vaginal Yeast Infection market sizes from 2021 to 2028, along with CAGR for 2023-2028
- Market size comparison for 2022 vs 2028, with actual data for 2022, estimates for 2023 and forecast from 2024 to 2028
- Global Vaginal Yeast Infection market trends, covering comprehensive range of consumer trends & manufacturer trends
- Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Vaginal Yeast Infection market
- Major market opportunities and challenges in forecast timeframe to be focused
- Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
- Comprehensive company profiles of the key industry players
Report Scope:
The global Vaginal Yeast Infection market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Vaginal Yeast Infection market share. Major industry players with significant revenue share include Astellas Pharma Inc, Astra Zeneca, Abbott Laboratories, Allergan, Brundavan Laboratories Private Limited, Bayer, Corden Pharma, Merck & Co., Inc., Novartis, Pfizer Inc, Synmedic Laboratories, Sanofi, and others.
Reasons to Buy this Report:
- Gain detailed insights on the Vaginal Yeast Infection industry trends
- Find complete analysis on the market status
- Identify the Vaginal Yeast Infection market opportunities and growth segments
- Analyse competitive dynamics by evaluating business segments & product portfolios
- Facilitate strategy planning and industry dynamics to enhance decision making
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
Medical Device Connectivity Market
Topical Use Acne Treatment Market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Market Research Process
2.3. Research Data Analysis
2.3.1.1. Secondary Research
2.3.1.2. Primary Research
2.3.1.3. Models for Estimation
2.4. Market Size Estimation
2.4.1. Bottom-Up Approach- Segmental Market Analysis
2.4.2. Top-Down Approach- Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1. Introduction
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. Porter's Five Force Analysis
5. Vaginal Yeast Infection Market, By Drug Type
5.1. Introduction
5.2. Fluconazole
5.2.1. Market Overview
5.2.2. Market Size and Forecast
5.3. Nystatin
5.3.1. Market Overview
5.3.2. Market Size and Forecast
5.4. Flucytosine
5.4.1. Market Overview
5.4.2. Market Size and Forecast
5.5. Others
5.5.1. Market Overview
5.5.2. Market Size and Forecast
6. Vaginal Yeast Infection Market, By Route of Administration
6.1. Introduction
6.2. Oral
6.2.1. Market Overview
6.2.2. Market Size and Forecast
6.3. Topical
6.3.1. Market Overview
6.3.2. Market Size and Forecast
7. Vaginal Yeast Infection Market, By Distribution Channel
7.1. Introduction
7.2. Hospital Pharmacies
7.2.1. Market Overview
7.2.2. Market Size and Forecast
7.3. Retail Pharmacies
7.3.1. Market Overview
7.3.2. Market Size and Forecast
7.4. Online Pharmacies
7.4.1. Market Overview
7.4.2. Market Size and Forecast
8. Vaginal Yeast Infection Market, By Geography
8.1. Introduction
8.2. North America
8.2.1. North America Vaginal Yeast Infection, By Drug Type
8.2.2. North America Vaginal Yeast Infection, By Route of Administration
8.2.3. North America Vaginal Yeast Infection, By Distribution Channel
8.3. Europe
8.3.1. Europe Vaginal Yeast Infection, By Drug Type
8.3.2. Europe Vaginal Yeast Infection, By Route of Administration
8.3.3. Europe Vaginal Yeast Infection, By Distribution Channel
8.4. Asia-Pacific
8.4.1. Asia-Pacific Vaginal Yeast Infection, By Drug Type
8.4.2. Asia-Pacific Vaginal Yeast Infection, By Route of Administration
8.4.3. Asia-Pacific Vaginal Yeast Infection, By Distribution Channel
8.5. Rest of the World
8.5.1. Rest of the World Vaginal Yeast Infection, By Drug Type
8.5.2. Rest of the World Vaginal Yeast Infection, By Route of Administration
8.5.3. Rest of the World Vaginal Yeast Infection, By Distribution Channel
9. Competitive Insights
9.1. Key Insights
9.2. Company Market Share Analysis
9.3. Strategic Outlook
9.3.1. Mergers & Acquisitions
9.3.2. New Product Developments
9.3.3. Portfolio/Production Capacity Expansions
9.3.4. Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5. Others
10. Company Profiles
10.1. Astellas Pharma Inc
10.1.1. Company Overview
10.1.2. Product/Service Landscape
10.1.3. Financial Overview
10.1.4. Recent Developments
10.2. Astra Zeneca
10.2.1. Company Overview
10.2.2. Product/Service Landscape
10.2.3. Financial Overview
10.2.4. Recent Developments
10.3. Abbott Laboratories
10.3.1. Company Overview
10.3.2. Product/Service Landscape
10.3.3. Financial Overview
10.3.4. Recent Developments
10.4. Allergan
10.4.1. Company Overview
10.4.2. Product/Service Landscape
10.4.3. Financial Overview
10.4.4. Recent Developments
10.5. Brundavan Laboratories Private Limited
10.5.1. Company Overview
10.5.2. Product/Service Landscape
10.5.3. Financial Overview
10.5.4. Recent Developments
10.6. Bayer
10.6.1. Company Overview
10.6.2. Product/Service Landscape
10.6.3. Financial Overview
10.6.4. Recent Developments
10.7. Corden Pharma
10.7.1. Company Overview
10.7.2. Product/Service Landscape
10.7.3. Financial Overview
10.7.4. Recent Developments
10.8. Merck & Co., Inc.
10.8.1. Company Overview
10.8.2. Product/Service Landscape
10.8.3. Financial Overview
10.8.4. Recent Developments
10.9. Novartis
10.9.1. Company Overview
10.9.2. Product/Service Landscape
10.9.3. Financial Overview
10.9.4. Recent Developments
10.10. Pfizer Inc
10.10.1. Company Overview
10.10.2. Product/Service Landscape
10.10.3. Financial Overview
10.10.4. Recent Developments
10.11. Synmedic Laboratories
10.11.1. Company Overview
10.11.2. Product/Service Landscape
10.11.3. Financial Overview
10.11.4. Recent Developments
10.12. Sanofi
10.12.1. Company Overview
10.12.2. Product/Service Landscape
10.12.3. Financial Overview
10.12.4. Recent Developments
The Vaginal Yeast Infection Market has been segmented as below:
Vaginal Yeast Infection Market, By Drug Type
- Fluconazole
- Nystatin
- Flucytosine
- Others
Vaginal Yeast Infection Market, By Route of Administration
- Oral
- Topical
Vaginal Yeast Infection Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Vaginal Yeast Infection Market, By Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Vaginal Yeast Infection Market, By Company
- Astellas Pharma Inc
- Astra Zeneca
- Abbott Laboratories
- Allergan
- Brundavan Laboratories Private Limited
- Bayer
- Corden Pharma
- Merck & Co., Inc.
- Novartis
- Pfizer Inc
- Synmedic Laboratories
- Sanofi
Got a question? We've got answers. If you have some other questions, see our support center.
What is the predicted growth rate of Vaginal Yeast Infection Market?
The market is expected to grow at a CAGR of 5% during the study period (2023-2028)
How big is the Vaginal Yeast Infection Market value?
The Vaginal Yeast Infection Market is expected to be around US$ 1,500 Million by 2028
What is the segment’s covered for the Vaginal Yeast Infection Market?
The segment included in Vaginal Yeast Infection Market is Drug Type, Route of Administration, Distribution Channel and region.
Who are the major key vendors in the Vaginal Yeast Infection Market?
Some key players operating in Vaginal Yeast Infection Market include Astellas Pharma Inc, Astra Zeneca, Abbott Laboratories, Allergan, Brundavan Laboratories Private Limited, Bayer, Corden Pharma, Merck & Co., Inc
What are the different forms of the report available?
We can offer several formats of the market research reports including,
• PDF
• PPT
• Spreadsheet/ Workbook
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE